Search
for
Sort by
Research 31–60 of 1000+
- Hétérogénéité tumorale du cancer de la prostate et infection par le SARS-CoV2 : une relation complexe impliquant les vésicules extracellulaires et le récepteur des androgènes
- The effect of low-level laser therapy on severe acute respiratory syndrome coronavirus-2 infected cells
- The antiviral activity of a small molecule drug targeting the NSP1-ribosome complex against Omicron, especially in elderly patients
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS‐CoV‐2 in the respiratory tract
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
- Symptoms compatible with long-COVID in healthcare workers with and without SARS-CoV-2 infection – results of a prospective multicenter cohort
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- COVID-19 and androgenic status: testosterone or dihydrotestosterone have a pivotal role?
- ВЛИЯНИЕ АНДРОГЕННОГО СТАТУСА И АНТИАНДРОГЕННОЙ ТЕРАПИИ НА ТЕЧЕНИЕ COVID-19 У МУЖЧИН
- Associations between clinical data, vaccination status, antibody responses, and post-COVID-19 symptoms in Thais infected with SARS-CoV-2 Delta and Omicron variants: a 1-year follow-up study
- SARS-CoV-2 vaccination in androgen sensitive phenotypes – A study on associated factors for SARS-CoV-2 vaccination and its adverse effects among androgenetic alopecia and benign prostate hyperplasia patients
- Intra-host SARS-CoV-2 single-nucleotide variants emerged during the early stage of COVID-19 pandemic forecast population fixing mutations
- Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity
- SARS-CoV-2 Infection—A Trigger Factor for Telogen Effluvium: Review of the Literature with a Case-Based Guidance for Clinical Evaluation
- Neurological post‐acute sequelae of SARS‐CoV‐2 infection
- The impact of SARS-CoV-2 and COVID-19 on male reproduction and men’s health
- Telogen effluvium related to post severe Sars‐Cov‐2 infection: Clinical aspects and our management experience
- Asymptomatic SARS-COV2 Infection or COVID-19 vaccination effect for severe multisystem inflammatory syndrome in a 6-year-old girl: case report and review of the literature
- Two years of SARS-CoV-2 infection (2019–2021): structural biology, vaccination, and current global situation
- Spiking dependence of SARS‐CoV‐2 pathogenicity on TMPRSS2
- From bedside to bench: regulation of host factors in SARS-CoV-2 infection
- Sex hormones in SARS-CoV-2 susceptibility: key players or confounders?
- Low neutralizing antibody titers after asymptomatic or non-severe SARS-CoV-2 infection over a 6-month assessment period
- Role of testosterone in SARS-CoV-2 infection: A key pathogenic factor and a biomarker for severe pneumonia
- A narrative review of SARS-CoV-2 variants and long COVID
- Research progress of post-acute sequelae after SARS-CoV-2 infection
- Genomic Surveillance Reveals the Rapid Expansion of the XBB Lineage among Circulating SARS-CoV-2 Omicron Lineages in Southeastern Wisconsin, USA
- Genetic Variants and Protective Immunity against SARS-CoV-2